The Association Between Recombinant Tissue Plasminogen Activator and Post-ischemic Stroke Seizure: A Retrospective Cohort Study
Background: Recombinant tissue plasminogen activator (r-tPA) has remained the primary therapeutic intervention for ischemic stroke when administered within the recommended time window. Despite its well-established benefits, potential side effects—glutamate release, increased leukocyte activity, and...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Guilan University of Medical Sciences
2025-07-01
|
| Series: | Caspian Journal of Neurological Sciences |
| Subjects: | |
| Online Access: | http://cjns.gums.ac.ir/article-1-780-en.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849427821744619520 |
|---|---|
| author | Hanie Khoshtarash Alia Saberi Hamidreza Hatamian Ali Ashraf Somayeh Ahmadi Mohammad Ali Yazdanipour |
| author_facet | Hanie Khoshtarash Alia Saberi Hamidreza Hatamian Ali Ashraf Somayeh Ahmadi Mohammad Ali Yazdanipour |
| author_sort | Hanie Khoshtarash |
| collection | DOAJ |
| description | Background: Recombinant tissue plasminogen activator (r-tPA) has remained the primary therapeutic intervention for ischemic stroke when administered within the recommended time window. Despite its well-established benefits, potential side effects—glutamate release, increased leukocyte activity, and oxidative stress—should also be considered. Among these concerns, the development of post-stroke seizures (PSS) has gained attention as a possible complication.
Objectives: This study explored the association between r-tPA administration and the likelihood of post-stroke seizure.
Materials & Methods: A retrospective cohort of 200 patients, split evenly between those treated with r-tPA and those who were not, was analyzed at an academic hospital in northern Iran over three years (2017–2020). Clinical parameters were collected and compared, including demographics, medical history, involved artery, NIHSS (the National Institutes of Health Stroke scale) values on admission, the Alberta stroke program early CT score (ASPECTS), and post-stroke seizure occurrence.
Results: Nineteen patients (10%) developed seizures; 8 of them (8%) belonged to the group without r-tPA, and 11(11%) belonged to the r-tPA group (P=0.469). Results showed no significant relationship between developing seizures and r-tPA therapy. This study shows that the ASPECT score is the only parameter associated with the risk of post-stoke seizure. By increasing one score in ASPECTS, the rate of seizure occurrence decreases by 24.
Conclusion: These outcomes confirm the continued use of r-tPA as a safe and effective treatment option for ischemic stroke patients. |
| format | Article |
| id | doaj-art-d563ab6f9bda43c6a7964a789359c731 |
| institution | Kabale University |
| issn | 2423-4818 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Guilan University of Medical Sciences |
| record_format | Article |
| series | Caspian Journal of Neurological Sciences |
| spelling | doaj-art-d563ab6f9bda43c6a7964a789359c7312025-08-20T03:28:54ZengGuilan University of Medical SciencesCaspian Journal of Neurological Sciences2423-48182025-07-01113237244The Association Between Recombinant Tissue Plasminogen Activator and Post-ischemic Stroke Seizure: A Retrospective Cohort StudyHanie Khoshtarash0Alia Saberi1Hamidreza Hatamian2Ali Ashraf3Somayeh Ahmadi4Mohammad Ali Yazdanipour5 Department of Neurology, Neurosciences Research Center, Faculty of Medicine, Poursina Hospital, Guilan University of Medical Sciences, Rasht, Iran. Department of Neurology, Neurosciences Research Center, Faculty of Medicine, Poursina Hospital, Guilan University of Medical Sciences, Rasht, Iran. Department of Neurology, Neurosciences Research Center, Faculty of Medicine, Poursina Hospital, Guilan University of Medical Sciences, Rasht, Iran. Clinical Research Development Unit, Poursina Hospital, Guilan University of Medical Sciences, Rasht, Iran. Department of Biostatistics, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Neuroscience Research Center, Trauma Institute, Guilan University of Medical Sciences, Rasht, Iran. Background: Recombinant tissue plasminogen activator (r-tPA) has remained the primary therapeutic intervention for ischemic stroke when administered within the recommended time window. Despite its well-established benefits, potential side effects—glutamate release, increased leukocyte activity, and oxidative stress—should also be considered. Among these concerns, the development of post-stroke seizures (PSS) has gained attention as a possible complication. Objectives: This study explored the association between r-tPA administration and the likelihood of post-stroke seizure. Materials & Methods: A retrospective cohort of 200 patients, split evenly between those treated with r-tPA and those who were not, was analyzed at an academic hospital in northern Iran over three years (2017–2020). Clinical parameters were collected and compared, including demographics, medical history, involved artery, NIHSS (the National Institutes of Health Stroke scale) values on admission, the Alberta stroke program early CT score (ASPECTS), and post-stroke seizure occurrence. Results: Nineteen patients (10%) developed seizures; 8 of them (8%) belonged to the group without r-tPA, and 11(11%) belonged to the r-tPA group (P=0.469). Results showed no significant relationship between developing seizures and r-tPA therapy. This study shows that the ASPECT score is the only parameter associated with the risk of post-stoke seizure. By increasing one score in ASPECTS, the rate of seizure occurrence decreases by 24. Conclusion: These outcomes confirm the continued use of r-tPA as a safe and effective treatment option for ischemic stroke patients.http://cjns.gums.ac.ir/article-1-780-en.pdfseizureischemic stroketissue plasminogen activator |
| spellingShingle | Hanie Khoshtarash Alia Saberi Hamidreza Hatamian Ali Ashraf Somayeh Ahmadi Mohammad Ali Yazdanipour The Association Between Recombinant Tissue Plasminogen Activator and Post-ischemic Stroke Seizure: A Retrospective Cohort Study Caspian Journal of Neurological Sciences seizure ischemic stroke tissue plasminogen activator |
| title | The Association Between Recombinant Tissue Plasminogen Activator and Post-ischemic Stroke Seizure: A Retrospective Cohort Study |
| title_full | The Association Between Recombinant Tissue Plasminogen Activator and Post-ischemic Stroke Seizure: A Retrospective Cohort Study |
| title_fullStr | The Association Between Recombinant Tissue Plasminogen Activator and Post-ischemic Stroke Seizure: A Retrospective Cohort Study |
| title_full_unstemmed | The Association Between Recombinant Tissue Plasminogen Activator and Post-ischemic Stroke Seizure: A Retrospective Cohort Study |
| title_short | The Association Between Recombinant Tissue Plasminogen Activator and Post-ischemic Stroke Seizure: A Retrospective Cohort Study |
| title_sort | association between recombinant tissue plasminogen activator and post ischemic stroke seizure a retrospective cohort study |
| topic | seizure ischemic stroke tissue plasminogen activator |
| url | http://cjns.gums.ac.ir/article-1-780-en.pdf |
| work_keys_str_mv | AT haniekhoshtarash theassociationbetweenrecombinanttissueplasminogenactivatorandpostischemicstrokeseizurearetrospectivecohortstudy AT aliasaberi theassociationbetweenrecombinanttissueplasminogenactivatorandpostischemicstrokeseizurearetrospectivecohortstudy AT hamidrezahatamian theassociationbetweenrecombinanttissueplasminogenactivatorandpostischemicstrokeseizurearetrospectivecohortstudy AT aliashraf theassociationbetweenrecombinanttissueplasminogenactivatorandpostischemicstrokeseizurearetrospectivecohortstudy AT somayehahmadi theassociationbetweenrecombinanttissueplasminogenactivatorandpostischemicstrokeseizurearetrospectivecohortstudy AT mohammadaliyazdanipour theassociationbetweenrecombinanttissueplasminogenactivatorandpostischemicstrokeseizurearetrospectivecohortstudy AT haniekhoshtarash associationbetweenrecombinanttissueplasminogenactivatorandpostischemicstrokeseizurearetrospectivecohortstudy AT aliasaberi associationbetweenrecombinanttissueplasminogenactivatorandpostischemicstrokeseizurearetrospectivecohortstudy AT hamidrezahatamian associationbetweenrecombinanttissueplasminogenactivatorandpostischemicstrokeseizurearetrospectivecohortstudy AT aliashraf associationbetweenrecombinanttissueplasminogenactivatorandpostischemicstrokeseizurearetrospectivecohortstudy AT somayehahmadi associationbetweenrecombinanttissueplasminogenactivatorandpostischemicstrokeseizurearetrospectivecohortstudy AT mohammadaliyazdanipour associationbetweenrecombinanttissueplasminogenactivatorandpostischemicstrokeseizurearetrospectivecohortstudy |